Eastman Chemical misses by $0.06, beats on revs; guides FY22 EPS in-line, revenue above consensus (118.54 -0.57)
- Reports Q4 (Dec) earnings of $1.81 per share, excluding non-recurring items, $0.06 worse than the S&P Capital IQ Consensus of $1.87; revenues rose 23.2% year/year to $2.69 bln vs the $2.38 bln S&P Capital IQ Consensus.
- Co issues in-line EPS guidance for FY22, sees EPS of $9.50-$10.00 vs. $9.72 S&P Capital IQ Consensus. Expects FY22 revenue to be higher than FY21 revenue of $10.48 bln compared to the $9.8 bln S&P Capital IQ consensus estimate.